Early detection and characterization of new variants and their impacts enable improved
genomic surveillance. This study aims to evaluate the subvariant distribution of Omicron …

As of November 2021, the SARS-CoV-2 Omicron variant had made its appearance,
gradually replacing the predominant Delta variant. Since its emergence, the Omicron variant …

Omicron variants have been classified as Variants of Concern (VOC) by the World Health
Organization (WHO) ever since they first emerged as a result of a significant mutation in this …

Objective In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked
in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases …

The aim of this study was to investigate and obtain insights into the appearance, spread and
impact of the Omicron variants and their sub-lineages in Cyprus by analyzing 611 high …

Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …

Background The o severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic has
killed millions of people and caused widespread concern around the world. Multiple genetic …

In January 2022, there was a global and rapid surge of the Omicron variant of SARS-CoV-2
related to more transmission. This coincided with an increase in the incidence in Asturias, a …

Background: Since the beginning of the recent pandemic in December 2019, the growing
waves of SARS-CoV-2 infection have been a major concern. Also, SARS-CoV-2 itself is …

Purpose Omicron (B. 1.1. 529) is one of the highly mutated variants of concern of SARS-CoV-
2. Lineages of Omicron bear a remarkable degree of mutations leading to enhanced …